Checking XERS unusual options activity helps you spot when traders are making outsized bets on Xeris Biopharma Holdings Inc before the broader market catches on. Xeris Biopharma Holdings Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor XERS unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching XERS unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking XERS unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and XERS unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect.
The company was incorporated in 2005 and is headquartered in Chicago, Illinois.
Catalysts rarely arrive without a footprint, and XERS unusual options activity is often where that footprint shows up first. Our scanner tracks Xeris Biopharma Holdings Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at XERS unusual options volume on the call side or chasing put sweeps, Xeris Biopharma Holdings Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
